TRUP NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Trupanion Inc · Financial Services · Insurance - Property & Casualty

Open interactive chart View report data
Latest close 24.49 USD
2.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -7.8% below the Trend Line and sits at 9.3% of its 52-week range. The latest completed week returned 2.1%, after a -9.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 54/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 23 out of 100
Latest Close 24.49 USD 31 Jul 2026
1W Return 2.1% latest completed week
4W Return -9.0% short-term follow-through
12W Return -0.5% quarterly tape
Trend Breadth 13.5% 7 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 44.62% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.1% Latest completed week; four-week move -9.0%. Indicator stack 7/62 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 44.62% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 54/100 conviction; expected move 17.6%. News sentiment 53/100 39 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -7.8% below the Trend Line and sits at 9.3% of its 52-week range. The latest completed week returned 2.1%, after a -9.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1112-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.11Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -9.0% over four weeks, -0.5% over 12 weeks, and -47.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W2.1%
4W-9.0%
12W-0.5%
26W-23.4%
52W-47.0%
Active trend streak0 weeks
Active weeks in one year7
Trend breadth13.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.71Latest activity-pressure read.
Pressure change-11.1%Four-week change in activity pressure.
Leadership-32.87Latest relative-leadership reading.
RS change2.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength8/100Blend of value, momentum, and quality. Underlying universe rank 93; rank 1 is best.
Value29/100Relative valuation strength. Underlying universe rank 72; rank 1 is best.
Quality33/100Profitability and accounting quality. Underlying universe rank 68; rank 1 is best.
Momentum5/100Medium-term price momentum. Underlying universe rank 96; rank 1 is best.
Growth72/100Revenue and earnings growth. Underlying universe rank 29; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework32/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
40.6x
Price divided by trailing earnings.
Price / sales
0.7x
Market value relative to trailing revenue.
EV / EBITDA
17.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
10.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
22.4%
Gross profit retained from each unit of revenue.
Operating margin
2.8%
Operating profit retained from revenue.
Free-cash-flow margin
6.8%
Free cash flow generated from revenue.
Return on invested capital
10.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
12.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
43.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.2%
Net share repurchases relative to market value.
Shareholder yield
0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

TRUP shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 0.09, expected move of 17.6%, and Sharemaestro trend signal inactive.

Conviction54/100
Expected move17.6%
Put/call volume0.09
Pressure90
Speculation31
Volatility96
Trend agreement0
Open options detail
Insider activity14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment53/100

Weighted news tone is neutral across 39 relevant articles.

8 positive · 27 neutral · 4 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move17.6%Nearest-chain priced movement where available.
52-week drawdown-57.0%Distance below the 52-week high.
13-week volatility5.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+14.9%Week of 17 Apr.
Worst week-15.7%Week of 13 Feb.
Latest week+2.1%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains8
Flat weeks0
Modest losses5
Sharp losses8
Recent vol5.4%13-week weekly-return volatility.
Base vol5.6%52-week weekly-return volatility.
Up/down split20/32Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -4.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape22/100

Trend, activity pressure, participation, and risk combine to a 22/100 tape read.

 Indicator analysis24/100

Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.

Activity pressure 0.11; No reversal markers Next-Week ExpectancyNegative 44.62%

Next-week expectancy is negative with a 44.62% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors18/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 39; Small Cap Core rank 74 SVQF32/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 495.0 of 726 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options36/100

TRUP shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 0.09, expected move of 17.6%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 17.6% Sentiment53/100

Weighted news tone is neutral across 39 relevant articles.

Form 4 Trupanion Inc For: 30 July By Investing.com Insiders14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202624.49 USD2.1%26.57 USD35.51 USD0.71-32.871.7MOff
24 Jul 202623.99 USD-10.1%27.00 USD35.55 USD0.89-35.021.5MOff
17 Jul 202626.70 USD3.4%27.45 USD35.59 USD1.12-30.161.6MOff
10 Jul 202625.83 USD-4.0%27.83 USD35.59 USD0.96-36.421.5MOff
3 Jul 202626.91 USD6.2%28.18 USD35.58 USD0.80-33.801.7MOff
26 Jun 202625.35 USD7.7%28.52 USD35.58 USD0.50-38.302.0MOff
19 Jun 202623.54 USD-0.5%28.85 USD35.54 USD0.11-46.471.8MOff
12 Jun 202623.65 USD7.5%29.26 USD35.53 USD-0.03-46.091.7MOff
5 Jun 202622.00 USD0.8%29.73 USD35.55 USD-0.21-49.711.9MOff
29 May 202621.82 USD-0.7%30.28 USD35.57 USD-0.19-53.271.4MOff
22 May 202621.98 USD-1.6%30.89 USD35.58 USD-0.04-52.462.2MOff
15 May 202622.33 USD-9.3%31.61 USD35.57 USD0.02-51.942.0MOff
8 May 202624.61 USD1.2%32.30 USD35.56 USD0.10-48.092.0MOff
1 May 202624.33 USD-11.4%32.86 USD35.54 USD-0.27-46.732.7MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.